Comparing and combining xevinapant with ATR and PARP inhibition for the radiosensitization of HPV-negative HNSCC cells.

tuvusertib (M1774) - EMD Serono

xevinapant (Debio 1143) - EMD Serono

Lynparza (olaparib) - Merck (MSD), AstraZeneca

cisplatin - Generic mfg.

http://www.ncbi.nlm.nih.gov/pubmed/41673235

Adriana Perugachi-Heinsohn; Christian Betz; Cordula Petersen; Fruzsina Gatzemeier; Henrike Barbara Zech; Julius Roehrle; Kai Rothkamm; Malte Kriegs; Sabrina Christiansen; Thorsten Rieckmann

Feb 12, 2026